Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Kimia Biosciences Ltd (NSE: KIMIABL), ISIN INE285U01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
KIMIABL last traded at ₹30.60 (-0.26%), with a 52-week range of ₹23.20 to ₹43.28 (as of 23 Sep 2026).
Shareholding as of Dec 2025: promoters 74.94%, FIIs 0.00%, DIIs 0.38%, mutual funds 0.38%.
EquiSense Score (ECS): 49/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.